ArTS Archivio della ricerca di Trieste

DECORTI, GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.398
EU - Europa 11.616
AS - Asia 9.879
SA - Sud America 1.194
AF - Africa 358
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 11
Totale 44.497
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.097
SG - Singapore 3.674
PL - Polonia 2.738
IT - Italia 2.359
CN - Cina 2.141
SE - Svezia 1.286
VN - Vietnam 1.108
UA - Ucraina 978
BR - Brasile 913
HK - Hong Kong 912
DE - Germania 829
FI - Finlandia 634
FR - Francia 569
GB - Regno Unito 531
KR - Corea 444
BD - Bangladesh 422
RU - Federazione Russa 414
TR - Turchia 307
NL - Olanda 302
IE - Irlanda 250
IN - India 229
BG - Bulgaria 222
CA - Canada 138
JP - Giappone 124
MA - Marocco 106
AR - Argentina 100
MX - Messico 92
BE - Belgio 83
ES - Italia 71
IQ - Iraq 71
PK - Pakistan 64
ZA - Sudafrica 58
AT - Austria 57
SN - Senegal 54
CH - Svizzera 51
ID - Indonesia 48
CZ - Repubblica Ceca 46
EC - Ecuador 39
SA - Arabia Saudita 39
PH - Filippine 35
AU - Australia 34
TH - Thailandia 34
EG - Egitto 32
CL - Cile 31
CO - Colombia 31
TN - Tunisia 31
UZ - Uzbekistan 28
VE - Venezuela 26
PT - Portogallo 23
AE - Emirati Arabi Uniti 22
PE - Perù 22
JO - Giordania 20
RO - Romania 19
GR - Grecia 18
AZ - Azerbaigian 17
IL - Israele 17
KE - Kenya 17
MY - Malesia 17
PY - Paraguay 17
SI - Slovenia 16
TW - Taiwan 16
RS - Serbia 15
DZ - Algeria 14
DK - Danimarca 13
IR - Iran 12
JM - Giamaica 12
LT - Lituania 11
NO - Norvegia 10
CR - Costa Rica 9
MD - Moldavia 9
NP - Nepal 9
AL - Albania 8
EU - Europa 8
KW - Kuwait 8
NG - Nigeria 8
PA - Panama 8
UY - Uruguay 8
ET - Etiopia 7
HR - Croazia 7
LB - Libano 7
BA - Bosnia-Erzegovina 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
EE - Estonia 6
GT - Guatemala 6
HU - Ungheria 6
KZ - Kazakistan 6
LK - Sri Lanka 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
BY - Bielorussia 5
GA - Gabon 5
HN - Honduras 5
KG - Kirghizistan 5
LU - Lussemburgo 5
SK - Slovacchia (Repubblica Slovacca) 5
CI - Costa d'Avorio 4
GE - Georgia 4
MN - Mongolia 4
Totale 44.414
Salva come PNG Salva come JPEG
Città #
Warsaw 2.477
Ashburn 2.236
Singapore 2.219
Woodbridge 2.164
Ann Arbor 1.851
Fairfield 1.848
Houston 1.359
Chandler 1.315
San Jose 1.094
Wilmington 886
Hong Kong 882
Jacksonville 855
Seattle 821
Trieste 688
Cambridge 591
Beijing 484
Seoul 419
Princeton 392
Hefei 376
Boardman 366
Munich 338
Ho Chi Minh City 326
Los Angeles 285
Hanoi 278
Chicago 275
Helsinki 270
Dublin 229
Izmir 227
Milan 221
Sofia 220
Lauterbourg 219
Council Bluffs 218
Columbus 213
Zgierz 200
Dallas 196
Moscow 194
Santa Clara 175
London 174
New York 163
The Dalles 157
Buffalo 144
Frankfurt am Main 144
Dearborn 131
São Paulo 107
San Diego 98
Düsseldorf 91
Casablanca 87
Rome 86
Brussels 78
Tokyo 75
Shanghai 63
Orem 61
Dakar 54
Atlanta 53
Phoenix 51
Des Moines 50
Memphis 50
Redondo Beach 48
Da Nang 45
Turku 45
Montreal 43
Falls Church 42
Guangzhou 42
Amsterdam 41
Denver 41
Haiphong 41
Chennai 39
Manchester 39
Toronto 38
Brno 37
Nuremberg 37
Dong Ket 36
Johannesburg 36
Nanjing 36
Vienna 36
Wroclaw 36
Brooklyn 35
Mumbai 35
Stockholm 35
Bern 34
Tianjin 34
Washington 34
Bremen 33
Miano 33
Redwood City 32
Curitiba 31
Jinan 31
Lappeenranta 30
Baghdad 28
Tashkent 27
Verona 26
Rio de Janeiro 25
Kunming 24
Norwalk 24
Shenyang 24
Bologna 23
Fremont 23
Paris 23
San Francisco 23
Istanbul 22
Totale 30.771
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 536
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis 527
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 512
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 485
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 470
Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines' Toxic Effects 456
Pharmacogenetics of thiopurines 451
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms 430
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 428
Genetic determinants for methotrexate response in juvenile idiopathic arthritis 415
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 415
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? 403
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 399
Pharmacogenetics of treatments for inflammatory bowel disease 381
In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome 342
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 329
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 313
Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide 310
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 309
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 292
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 291
Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes 288
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease 288
Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. 287
Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment 285
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 285
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 278
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. 275
Ergothioneine, a dietary amino acid with a high relevance for the interpretation of label-free surface enhanced Raman scattering (SERS) spectra of many biological samples 270
Effect of thalidomide on clinical remission in children and adolescents with ulcerative colitis refractory to other immunosuppressives: Pilot randomized clinical trial 269
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 269
Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells. 268
Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability 268
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. 267
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 266
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 266
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 265
Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. 264
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 262
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 260
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 259
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 256
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 255
Amelioration of 4'-Epidoxorubicin-induced cardiotoxicity by sodium cromoglycate. 254
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient 253
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 251
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 251
Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient 250
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT∗3 alleles 249
Hemolytic Effects of Water-Soluble Fullerene Derivatives 247
Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. 244
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse. 242
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 240
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 238
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. 237
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 236
Glutathione-S-Transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome 233
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 233
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol 232
Anticonvulsant activity of two polyethylene glycols in mice. 230
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 230
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 229
The cytotoxic effect of palytoxin on Caco-2 cells hinders their use for in vitro absorption studies. 228
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know 228
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 226
Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells. 225
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease 224
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches. 224
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 224
Adriamycin binds to the matrix of secretory granules during mast cell exocytosis. 223
Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. 223
SERS of cells: What can we learn from cell lysates? 223
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 222
ABCB1 gene polymorphisms and expression of P-glycoprotein and long term prognosis in colorectal cancer 222
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 222
Biochemical and microscopic evidence for the internalization of drug-containing mast cell granules by macrophages and smooth muscle cells 219
Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. 219
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. 217
Effect of neomycin and other aminoglycosides on adriamycin uptake in rat peritoneal mast cells. 216
Effect of periodontal therapy on the course of cyclosporin-induced gingival overgrowth: role of ABCB1 and PAI-1 gene polymorphisms. 216
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 215
Glucocorticoids in Pediatric Gastrointestinal Disorders 213
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. 210
Effect of ketotifen on adriamycin toxicity: role of histamine. 210
Selective resistance to different glucocorticoids in severe autoimmune disorders 207
Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases 207
Cellular antioxidant activities and cytotoxic properties of ethanolic extracts of four tropical green leafy vegetables 205
Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice. 205
Osteonecrosis of the hip after short courses of oral and inhaled steroids in a child with an increased number of glucocorticoid receptors 205
Visualization of adriamycin uptake and internalization by receptor-mediated endocytosis in mast cells. An ultrastructural study using adriamycin-colloidal gold complexes. 204
Glutathione S-Transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. 204
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype 204
Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. 203
Adriamycin-induced histamine release from heart tissue in vitro. 203
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 203
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 201
Personalized therapies in pediatric inflammatory and autoimmune diseases. 201
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance 201
Letter: TPMT activity and age in IBD patients. 200
Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart 197
Totale 27.122
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021309 0 0 0 0 0 0 0 0 0 0 0 309
2021/20222.595 124 158 123 243 56 225 186 104 299 277 160 640
2022/20233.860 372 559 271 571 369 647 32 318 425 57 162 77
2023/20242.382 128 170 107 139 249 197 444 460 39 66 225 158
2024/20256.105 120 245 401 573 571 644 415 418 780 767 575 596
2025/202613.560 1.306 633 825 1.065 1.230 1.265 2.022 430 1.553 1.862 856 513
Totale 45.443